On the public citation graph

Disease‐specific waitlist outcomes in liver transplantation – a retrospective study

0 signed · 46 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.28923openalex-snapshot

Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy

inferredcites →https://doi.org/10.1002/hep.31223openalex-snapshot

Effect of Mandatory 6‐Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma

inferredcites →https://doi.org/10.1002/lt.22396openalex-snapshot

Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era

inferredcites →https://doi.org/10.1002/lt.24764openalex-snapshot

Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma

inferredcites →https://doi.org/10.1002/lt.25485openalex-snapshot

Superior Wait‐List Outcomes in Patients with Alcohol‐Associated Liver Disease Compared With Other Indications for Liver Transplantation

inferredcites →https://doi.org/10.1016/j.cgh.2016.11.034openalex-snapshot

Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States

inferredcites →https://doi.org/10.1016/j.cgh.2018.05.057openalex-snapshot

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

inferredcites →https://doi.org/10.1016/j.cgh.2019.04.033openalex-snapshot

Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies

inferredcites →https://doi.org/10.1016/j.dld.2019.08.022openalex-snapshot

Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma

inferredcites →https://doi.org/10.1016/j.jhep.2018.02.012openalex-snapshot

The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition

inferredcites →https://doi.org/10.1053/j.gastro.2014.11.039openalex-snapshot

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

inferredcites →https://doi.org/10.1053/j.gastro.2018.07.025openalex-snapshot

Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease–Sodium Scores on Patient Outcomes

inferredcites →https://doi.org/10.1053/jlts.2000.6503openalex-snapshot

Adaptation of the mayo primary biliary cirrhosis natural history model for application in liver transplant candidates

inferredcites →https://doi.org/10.1053/jlts.2003.50009openalex-snapshot

Longitudinal assessment of mortality risk among candidates for liver transplantation

inferredcites →https://doi.org/10.1056/nejmoa0801209openalex-snapshot

Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

inferredcites →https://doi.org/10.1097/mot.0b013e32835fb94bopenalex-snapshot

Should length of sobriety be a major determinant in liver transplant selection?

inferredcites →https://doi.org/10.1111/ajt.15144openalex-snapshot

Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change

inferredcites →https://doi.org/10.1111/ajt.15559openalex-snapshot

The decreasing predictive power of MELD in an era of changing etiology of liver disease

inferredcites →https://doi.org/10.1111/j.1600-6143.2004.00593.xopenalex-snapshot

Preoperative Delta-MELD Score Does Not Independently Predict Mortality After Liver Transplantation

inferredcites →https://doi.org/10.1111/j.1600-6143.2004.00703.xopenalex-snapshot

The Survival Benefit of Liver Transplantation

inferredcites →https://doi.org/10.1111/tri.13097openalex-snapshot

Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4663331openalex-extracted

The Survival Benefit of Liver Transplantation for Metabolic Associated Steatotic Liver Disease: An Italian Liver Transplant Registry Study

inferred← citeshttps://doi.org/10.1002/hep.32141openalex-snapshot

With Alcohol as the Fuel, COVID Is the Match: Liver Transplantation for Alcohol‐Associated Liver Disease Is Increasing in the United States

inferred← citeshttps://doi.org/10.1002/jpn3.12378openalex-snapshot

Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group

inferred← citeshttps://doi.org/10.1002/lt.26442openalex-snapshot

Use of neural network models to predict liver transplantation waitlist mortality

inferred← citeshttps://doi.org/10.1016/j.aohep.2026.102201openalex-snapshot

Liver transplant outcomes in primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease overlap

inferred← citeshttps://doi.org/10.1016/j.cld.2023.01.003openalex-snapshot

Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis

inferred← citeshttps://doi.org/10.1016/j.dld.2024.08.039openalex-snapshot

Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study

inferred← citeshttps://doi.org/10.1016/j.gastha.2022.06.016openalex-snapshot

The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies

inferred← citeshttps://doi.org/10.1016/j.gastre.2026.502629openalex-snapshot

Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP

inferred← citeshttps://doi.org/10.1016/j.jhepr.2024.101147openalex-snapshot

Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study

inferred← citeshttps://doi.org/10.1016/j.mcna.2023.01.004openalex-snapshot

Liver Transplantation for the Nonhepatologist

inferred← citeshttps://doi.org/10.1016/j.transproceed.2025.08.019openalex-snapshot

Trends and Barriers in Liver Transplantation for Patients With Decompensated Cirrhosis: A 15-Year Single-Center Cohort at a Japanese Center

inferred← citeshttps://doi.org/10.1016/j.trre.2026.101024openalex-snapshot

Comparative waitlist mortality of autoimmune liver disease: A systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1038/s41574-022-00711-5openalex-snapshot

Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation

inferred← citeshttps://doi.org/10.1097/cld.0000000000000163openalex-snapshot

Which patient should be prioritized for liver transplant: NAFLD?

inferred← citeshttps://doi.org/10.1097/hep.0000000000000978openalex-snapshot

Liver transplantation for alcohol-associated liver disease

inferred← citeshttps://doi.org/10.1097/hep.0000000000001268openalex-snapshot

Liver transplantation for cholestatic liver diseases: Timing and disease recurrence

inferred← citeshttps://doi.org/10.1097/mcg.0000000000001992openalex-snapshot

Do Patients With NASH-related Cirrhosis Have Better Overall Survival Compared With Other Etiologies of Cirrhosis? A Population-based Study

inferred← citeshttps://doi.org/10.1111/liv.15735openalex-snapshot

Superiority of the new sex‐adjusted models to remove the female disadvantage restoring equity in liver transplant allocation

inferred← citeshttps://doi.org/10.21926/obm.transplant.2502247openalex-snapshot

Updates in Liver Transplantation for Alcohol-Related Liver Disease

inferred← citeshttps://doi.org/10.2196/68247openalex-snapshot

Forecasting Waitlist Trajectories for Patients With Metabolic Dysfunction–Associated Steatohepatitis Cirrhosis: A Neural Network Competing Risk Analysis

inferred← citeshttps://doi.org/10.3350/cmh.2022.0392openalex-snapshot

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management

inferred← citeshttps://doi.org/10.3389/ti.2023.11729openalex-snapshot

Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

inferred← citeshttps://doi.org/10.3389/ti.2026.16153openalex-snapshot

Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation

inferred← citeshttps://doi.org/10.3390/biomedicines14030531openalex-snapshot

When Atrial Fibrillation Meets Alcoholic Liver Cirrhosis: Can Direct Oral Anticoagulants Bridge the Therapeutic Gap?

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.